PIK3CA and cancer: The prevalence of changes in cancer-related genes/pathways was compatible with that reported in previous studies of treated advanced breast malignancies, including frequent oncogenic mutations in the PI3K pathway and loss-of-function mutations in the DNA damage response and tumor suppressor pathways [21, 22].